Impact of early vs. delayed initiation of dutasteride/ tamsulosin combination therapy on the risk of acute urinary retention or benign prostatic hyperplasia-related surgery: projections in Malaysia for benign prostatic enlargement at risk of disease progression

被引：0
|
作者：
Kapse, Sandip [1 ]
Palacios, Juan Manuel [2 ]
Malek, Rohan [3 ,4 ]
Zulkifli, Zainuddin [5 ]
Yeoh, Wei Sien [6 ]
Ngoo, Kay Seong [7 ]
Gandhi, Alap [1 ]
Demircan, Ipek [8 ]
机构：
[1] GSK Pharmaceut Malaysia Sdn Bhd, Petaling Jaya, Malaysia
[2] Global Med Urol, GSK, Madrid, Spain
[3] Damansara Specialist Hosp, Batu Caves, Selangor, Malaysia
[4] Hosp Selayang, Kuala Lumpur & Dept Urol, Batu Caves, Selangor, Malaysia
[5] Univ Kebangsaan Malaysia, Hosp Canselor Tuanku Mukhriz, Dept Surg, Kuala Lumpur, Malaysia
[6] Univ Malaya, Dept Surg, Urol Unit, Kuala Lumpur, Malaysia
[7] Hosp Angkatan Tentera Tuanku Mizan, Dept Surg, Kuala Lumpur, Malaysia
[8] GSK Plc, Brentford, England
来源：
BJU INTERNATIONAL | 2023年 / 132卷 / SUPP2期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
POS 021
引用
收藏
页码：12 / 12
页数：1
相关论文
共 25 条
  • [1] IMPACT OF EARLY VS. DELAYED INITIATION OF DUTASTERIDE/TAMSULOSIN COMBINATION THERAPY IN LOWER URINARY TRACT SYMPTOMS/BENIGN PROSTATIC HYPERPLASIA (LUTS/BPH) PATIENTS WITH MODERATE TO SEVERE SYMPTOMS AT RISK FOR PROGRESSION: RESULTS FROM CLINICAL TRIAL SIMULATIONS USING RISK OF RETENTION OR SURGERY
    Roehrborn, Claus
    D'Agate, Salvatore
    Chavan, Chandrashekhar
    Manyak, Michael
    Palacios-Moreno, Juan Manuel
    Oelke, Matthias
    Michel, Martin C.
    Della Pasqua, Oscar
    JOURNAL OF UROLOGY, 2020, 203 : E704 - E705
  • [2] Impact of early vs. delayed initiation of dutasteride/tamsulosin combination therapy on the risk of acute urinary retention or BPH-related surgery in LUTS/BPH patients with moderate-to-severe symptoms at risk of disease progression
    D'Agate, Salvatore
    Chavan, Chandrashekhar
    Manyak, Michael
    Palacios-Moreno, Juan Manuel
    Oelke, Matthias
    Michel, Martin C.
    Roehrborn, Claus G.
    Della Pasqua, Oscar
    WORLD JOURNAL OF UROLOGY, 2021, 39 (07) : 2635 - 2643
  • [3] Impact of early vs. delayed initiation of dutasteride/tamsulosin combination therapy on the risk of acute urinary retention or BPH-related surgery in LUTS/BPH patients with moderate-to-severe symptoms at risk of disease progression
    Salvatore D’Agate
    Chandrashekhar Chavan
    Michael Manyak
    Juan Manuel Palacios-Moreno
    Matthias Oelke
    Martin C. Michel
    Claus G. Roehrborn
    Oscar Della Pasqua
    World Journal of Urology, 2021, 39 : 2635 - 2643
  • [4] Benign Prostate Syndrome; Early Combination Therapy in Benign Prostatic Hyperplasia lowers the Risk of Progression
    不详
    AKTUELLE UROLOGIE, 2012, 43 (06) : B2 - B4
  • [5] Comparative effectiveness of silodosin vs. tamsulosin in treating acute urinary retention in benign prostatic hyperplasia patients
    Ul Hassan, Hassaan
    Gazder, Tanzeel-Ur-Rahman
    Khan, Nawaz
    Jafri, Abbas
    Hassan, Asad Shahzad
    Hashmi, Altaf
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2025, 75 (04) : 592 - 595
  • [6] A NEW RISK CALCULATOR TO PREDICT CHANGES IN INTERNATIONAL PROSTATE SYMPTOM SCORE AND RISK OF RETENTION OR SURGERY IN BENIGN PROSTATIC HYPERPLASIA PATIENTS WITH MODERATE-SEVERE SYMPTOMS AT RISK OF DISEASE PROGRESSION RECEIVING PLACEBO, DUTASTERIDE, TAMSULOSIN, OR COMBINATION THERAPY
    Roehrborn, Claus G.
    Palacios, Juan Manuel
    Thompson, Douglas
    Concas, Federico
    Kamola, Piotr J.
    Gravas, Stavros
    Oelke, Matthias
    Kattan, Michael
    Averbeck, Marcio A.
    Manyak, Michael
    Lulic, Zrinka
    JOURNAL OF UROLOGY, 2021, 206 : E488 - E488
  • [7] The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study
    Roehrborn, Claus G.
    Siami, Paul
    Barkin, Jack
    Damiao, Ronaldo
    Major-Walker, Kim
    Morrill, Betsy
    Montorsi, Francesco
    JOURNAL OF UROLOGY, 2008, 179 (02): : 616 - 621
  • [8] Effect of baseline variables on acute urinary retention and surgery related to benign prostatic hyperplasia in men from the combination of avodart and tamsulosin (CombAT) study
    Madersbacher, S.
    Roehrborn, C. G.
    Barkin, J.
    Tubaro, A.
    Wilson, T.
    Castro, R.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E748 - U590
  • [9] The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study - Comment
    Kaplan, Steven A.
    JOURNAL OF UROLOGY, 2008, 179 (02): : 621 - 621
  • [10] Earlier initiation of treatment with the dual 5α reductase inhibitor dutasteride reduces the risk of acute urinary retention and surgical intervention in men with benign prostatic hyperplasia
    Freedman, S
    Brosman, S
    Monica, S
    Emberton, M
    Feldman, R
    JOURNAL OF UROLOGY, 2004, 171 (04): : 358 - 358
123